End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10 CNY | -2.63% | 0.00% | -36.71% |
05-16 | Olymvax Biopharma's Flu Vaccine Gets China Nod for Clinical Trials | MT |
04-25 | Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 471
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Adsorbed Tetanus Vaccine
93.3
%
| 438 | 79.9 % | 463 | 93.3 % | +5.78% |
Haemophilus Influenzae Type B Conjugate Vaccine
5.5
%
| 55 | 10.0 % | 27 | 5.5 % | -50.10% |
Group A and Group C Meningococcal Polysaccharide Conjugate Vaccine
0.8
%
| 54 | 9.9 % | 4 | 0.8 % | -92.85% |
Other
0.4
%
| 1 | 0.1 % | 2 | 0.4 % | +127.76% |
Refined Tetanus Toxoid Stock Solution
0.0
%
| 0 | 0.0 % | 0 | 0.0 % | +83.33% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 547 | 100.0 % | 496 | 100.0 % | -9.38% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Shao Wen Fan
CEO | Chief Executive Officer | 71 | 31/12/09 |
Yong Tan
DFI | Director of Finance/CFO | 50 | 08/12/09 |
Qiang Wu
CTO | Chief Tech/Sci/R&D Officer | 48 | 31/12/10 |
Tian Jun Cheng
BRD | Director/Board Member | 34 | 31/12/12 |
Ai Min Chen
BRD | Director/Board Member | 69 | 31/12/08 |
Cheng Hu
BRD | Director/Board Member | 57 | 31/12/12 |
Fan Fan
BRD | Director/Board Member | 43 | 31/12/09 |
Wei Wu
SEC | Corporate Secretary | 42 | 08/12/09 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Shao Ping He
BRD | Director/Board Member | 67 | 23/04/19 |
Yun Hui Yu
BRD | Director/Board Member | 61 | 31/05/13 |
Fan Fan
BRD | Director/Board Member | 43 | 31/12/09 |
Cheng Hu
BRD | Director/Board Member | 57 | 31/12/12 |
Ai Min Chen
BRD | Director/Board Member | 69 | 31/12/08 |
Xian Chun Li
BRD | Director/Board Member | 57 | 23/04/19 |
Qiao Wang
BRD | Director/Board Member | 41 | 23/04/19 |
Peng Fei Zhang
CHM | Chairman | 39 | 31/05/16 |
Tian Jun Cheng
BRD | Director/Board Member | 34 | 31/12/12 |
Hua Yan
BRD | Director/Board Member | 59 | 17/05/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 406,907,300 | 187,474,099 ( 46.07 %) | 749,000 ( 0.1841 %) | 46.07 % |
Company contact information
Chengdu Olymvax Biopharmaceuticals, Inc.
99 Tianxin Road High-Tech Zone
611731, Chengdu
+
http://www.olymvax.comSector
Sales per Business
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-36.71% | 560M | |
+0.85% | 92.38B | |
-3.03% | 37.9B | |
-10.46% | 33.73B | |
+74.71% | 27.98B | |
-13.39% | 15.86B | |
-1.08% | 13.97B | |
-11.15% | 11.67B | |
+169.04% | 10.17B | |
-50.19% | 10.04B |
- Stock Market
- Equities
- 688319 Stock
- Company Chengdu Olymvax Biopharmaceuticals Inc.